Obinutuzumab, rituximab improved chlorambucil efficacy in CLL Healio CHICAGO — Response rates and survival outcomes with chlorambucil plus obinutuzumab or rituximab were superior to those with chlorambucil alone in a cohort of individuals with chronic lymphocytic leukemia, according to phase 3 study results presented ... |
